FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023658731> ?p ?o ?g. }

• W2023658731 endingPage "1605" @default.
• W2023658731 startingPage "1605" @default.
• W2023658731 abstract "Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments Panagiotis Bargiotas, Spyridon KonitsiotisDepartment of Neurology, University of Ioannina, Ioannina, GreeceAbstract: Parkinson’s disease therapy is still focused on the use of l-3,4-dihydroxyphenylalanine (levodopa or l-dopa) for the symptomatic treatment of the main clinical features of the disease, despite intensive pharmacological research in the last few decades. However, regardless of its effectiveness, the long-term use of levodopa causes, in combination with disease progression, the development of motor complications termed levodopa-induced dyskinesias (LIDs). LIDs are the result of profound modifications in the functional organization of the basal ganglia circuitry, possibly related to the chronic and pulsatile stimulation of striatal dopaminergic receptors by levodopa. Hence, for decades the key feature of a potentially effective agent against LIDs has been its ability to ensure more continuous dopaminergic stimulation in the brain. The growing knowledge regarding the pathophysiology of LIDs and the increasing evidence on involvement of nondopaminergic systems raises the possibility of more promising therapeutic approaches in the future. In the current review, we focus on novel therapies for LIDs in Parkinson’s disease, based mainly on agents that interfere with glutamatergic, serotonergic, adenosine, adrenergic, and cholinergic neurotransmission that are currently in testing or clinical development.Keywords: motor fluctuations, dopaminergic/nondopaminergic systems, pharmacotherapy" @default.
• W2023658731 created "2016-06-24" @default.
• W2023658731 creator A5034121897 @default.
• W2023658731 creator A5062918466 @default.
• W2023658731 date "2013-10-01" @default.
• W2023658731 modified "2023-10-02" @default.
• W2023658731 title "Levodopa-induced dyskinesias in Parkinson&rsquo;s disease: emerging treatments" @default.
• W2023658731 cites W1491076928 @default.
• W2023658731 cites W1518185094 @default.
• W2023658731 cites W1528597597 @default.
• W2023658731 cites W1557320868 @default.
• W2023658731 cites W1577054006 @default.
• W2023658731 cites W1900959796 @default.
• W2023658731 cites W1919886056 @default.
• W2023658731 cites W1926423117 @default.
• W2023658731 cites W1964705113 @default.
• W2023658731 cites W1964962588 @default.
• W2023658731 cites W1965232450 @default.
• W2023658731 cites W1966443363 @default.
• W2023658731 cites W1969609780 @default.
• W2023658731 cites W1971698832 @default.
• W2023658731 cites W1971779448 @default.
• W2023658731 cites W1972908219 @default.
• W2023658731 cites W1973564144 @default.
• W2023658731 cites W1974629517 @default.
• W2023658731 cites W1975843240 @default.
• W2023658731 cites W1976645888 @default.
• W2023658731 cites W1979512025 @default.
• W2023658731 cites W1980940635 @default.
• W2023658731 cites W1981170797 @default.
• W2023658731 cites W1981379480 @default.
• W2023658731 cites W1981806544 @default.
• W2023658731 cites W1982397024 @default.
• W2023658731 cites W1982761758 @default.
• W2023658731 cites W1986174590 @default.
• W2023658731 cites W1990269363 @default.
• W2023658731 cites W1994911797 @default.
• W2023658731 cites W1995472799 @default.
• W2023658731 cites W1997483903 @default.
• W2023658731 cites W1998534190 @default.
• W2023658731 cites W2000796102 @default.
• W2023658731 cites W2007390314 @default.
• W2023658731 cites W2011633861 @default.
• W2023658731 cites W2013762123 @default.
• W2023658731 cites W2016739274 @default.
• W2023658731 cites W2018560973 @default.
• W2023658731 cites W2019139425 @default.
• W2023658731 cites W2020658097 @default.
• W2023658731 cites W2024469991 @default.
• W2023658731 cites W2026629519 @default.
• W2023658731 cites W2029405505 @default.
• W2023658731 cites W2032628032 @default.
• W2023658731 cites W2036628697 @default.
• W2023658731 cites W2036936486 @default.
• W2023658731 cites W2037634451 @default.
• W2023658731 cites W2041840461 @default.
• W2023658731 cites W2043221233 @default.
• W2023658731 cites W2050028089 @default.
• W2023658731 cites W2052119205 @default.
• W2023658731 cites W2053473574 @default.
• W2023658731 cites W2058544402 @default.
• W2023658731 cites W2058897561 @default.
• W2023658731 cites W2060515314 @default.
• W2023658731 cites W2063405144 @default.
• W2023658731 cites W2070013653 @default.
• W2023658731 cites W2073196506 @default.
• W2023658731 cites W2074379417 @default.
• W2023658731 cites W2075621586 @default.
• W2023658731 cites W2077362648 @default.
• W2023658731 cites W2077841072 @default.
• W2023658731 cites W2078208735 @default.
• W2023658731 cites W2081391428 @default.
• W2023658731 cites W2088277236 @default.
• W2023658731 cites W2089704384 @default.
• W2023658731 cites W2093024051 @default.
• W2023658731 cites W2093325927 @default.
• W2023658731 cites W2094926547 @default.
• W2023658731 cites W2095868750 @default.
• W2023658731 cites W2096584733 @default.
• W2023658731 cites W2096737626 @default.
• W2023658731 cites W2096898998 @default.
• W2023658731 cites W2097863680 @default.
• W2023658731 cites W2102501184 @default.
• W2023658731 cites W2103120760 @default.
• W2023658731 cites W2103344372 @default.
• W2023658731 cites W2104396164 @default.
• W2023658731 cites W2105882492 @default.
• W2023658731 cites W2107758668 @default.
• W2023658731 cites W2108069241 @default.
• W2023658731 cites W2109407717 @default.
• W2023658731 cites W2112161239 @default.
• W2023658731 cites W2112467057 @default.
• W2023658731 cites W2114682795 @default.
• W2023658731 cites W2115222037 @default.
• W2023658731 cites W2115639304 @default.
• W2023658731 cites W2117455848 @default.
• W2023658731 cites W2119450744 @default.
• W2023658731 cites W2124106811 @default.

• next